News
CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...
1d
MedPage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesA once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...
While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target ...
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...
Now, a City of Hope study led by Geming Lu, M.D., assistant research professor, discovered that a protein called BNIP3 plays a critical role in preserving mitochondrial health and reducing the ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results